US Patent 9388144 Radiolabeled prostate specific membrane antigen inhibitors
Patent 9388144 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on July, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 25, 2014
Date of Patent
July 12, 2016
Patent Applicant
Patent Application Number
14553157
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9388144 Radiolabeled prostate specific membrane antigen inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.